These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27399353)

  • 1. Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.
    El Khoudary SR; Hutchins PM; Matthews KA; Brooks MM; Orchard TJ; Ronsein GE; Heinecke JW
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3419-28. PubMed ID: 27399353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
    Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men.
    Rubinow KB; Vaisar T; Chao JH; Heinecke JW; Page ST
    J Clin Lipidol; 2018; 12(4):1072-1082. PubMed ID: 29793828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Endogenous Hormones With HDL Novel Metrics Across the Menopause Transition: The SWAN HDL Study.
    El Khoudary SR; Nasr A; Billheimer J; Brooks MM; McConnell D; Crawford S; Orchard TJ; Rader DJ; Matthews KA
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e303-e314. PubMed ID: 34390340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL (High-Density Lipoprotein) Subclasses, Lipid Content, and Function Trajectories Across the Menopause Transition: SWAN-HDL Study.
    El Khoudary ( سمر رياض الخضري ) SR; Chen (陈曦润) X; Nasr ( ألكسس نصر ) AN; Billheimer J; Brooks MM; McConnell D; Orchard TJ; Crawford SL; Matthews KA; Rader DJ
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):951-961. PubMed ID: 33267661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
    He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Sean Davidson W; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
    Circulation; 2024 Mar; 149(10):774-787. PubMed ID: 38018436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
    Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
    Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
    He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
    Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.
    Nicholls SJ; Ruotolo G; Brewer HB; Kane JP; Wang MD; Krueger KA; Adelman SJ; Nissen SE; Rader DJ
    J Am Coll Cardiol; 2015 Nov; 66(20):2201-2210. PubMed ID: 26564598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: The RETRO HDLc cohort study.
    Costacou T; Miller RG; Bornfeldt KE; Heinecke JW; Orchard TJ; Vaisar T
    J Clin Lipidol; 2024; 18(2):e218-e229. PubMed ID: 38320926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy.
    Kockx M; Roberts L; Wang J; Tran C; Brown MA; Kritharides L
    Atheroscler Plus; 2022 Apr; 48():12-19. PubMed ID: 36644562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation.
    Minami-Takano A; Iwata H; Miyosawa K; Shiozawa T; Hayashi H; Funamizu T; Ishii K; Nozaki Y; Tabuchi H; Sekita G; Shimada K; Sumiyoshi M; Nakazato Y; Daida H; Minamino T
    Sci Rep; 2021 Feb; 11(1):3547. PubMed ID: 33574408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary stearic acid and palmitic acid do not differently affect ABCA1-mediated cholesterol efflux capacity in healthy men and postmenopausal women: A randomized controlled trial.
    van Rooijen MA; Plat J; Blom WAM; Zock PL; Mensink RP
    Clin Nutr; 2021 Mar; 40(3):804-811. PubMed ID: 32900520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT.
    Lucero D; Sviridov D; Freeman L; López GI; Fassio E; Remaley AT; Schreier L
    Atherosclerosis; 2015 Sep; 242(1):236-42. PubMed ID: 26232163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Density Lipoprotein Function Is Reduced in Patients Affected by Genetic or Idiopathic Hypogonadism.
    Adorni MP; Zimetti F; Cangiano B; Vezzoli V; Bernini F; Caruso D; Corsini A; Sirtori CR; Cariboni A; Bonomi M; Ruscica M
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3097-3107. PubMed ID: 30835274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration.
    Monette JS; Hutchins PM; Ronsein GE; Wimberger J; Irwin AD; Tang C; Sara JD; Shao B; Vaisar T; Lerman A; Heinecke JW
    Circ Res; 2016 Jun; 119(1):83-90. PubMed ID: 27114438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
    Asztalos BF; Hauser TH; Goldfine AB; Welty FK; Horvath KV; Schaefer EJ
    Atherosclerosis; 2022 Mar; 345():1-6. PubMed ID: 35183903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.